BREAKING
KVH Industries Inc (KVHI) Reports Q4 Earnings 9 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 9 hours ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 9 hours ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 9 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 10 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 10 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 10 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 10 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 11 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 11 hours ago KVH Industries Inc (KVHI) Reports Q4 Earnings 9 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 9 hours ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 9 hours ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 9 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 10 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 10 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 10 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 10 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 11 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 11 hours ago
ADVERTISEMENT
Analysis

JELD-WEN Reports Fourth-Quarter Revenue Of $802.0 Million, Narrows Net Loss

$JELD February 18, 2026 2 min read
NYSE
$JELD · Earnings

JELD-WEN Holding, Inc.

JELD-WEN Holding, Inc. (NYSE: JELD) reported that fourth-quarter revenue decreased 10.5% to $802.0 million from 40.1 million, or $0.47 per share, compared with a net loss of $68.4 million, or $0.81 per share, in the fourth quarter of 2024.

Latest Quarterly Results

Consolidated revenue for the quarter ended Dec. 31, 2025, totaled 40.1 million. Revenue growth was negative 10.5% year-over-year. The quarterly net loss narrowed by 41.4% compared to the $68.4 million loss recorded in the same period a year ago.

  • North America: Net revenues were $522.0 million, a decrease of 18.4% from $639.8 million. Core revenues declined 12%, driven by a 12% decrease in volume/mix attributed to weakened market demand. Net income from continuing operations for the segment was $68.1 million.
  • Europe: Net revenues were $280.0 million, an increase of 9.4% from $255.9 million. The result included a 9% favorable foreign exchange impact. Core revenues increased 1%, with the segment recording a net loss from continuing operations of $12.1 million.

Full-Year Results Context

Annual revenue for 2025 was $3.21 billion, a 14.9% decrease from 620.1 million, compared to $187.6 million in the prior year. Directional trends indicate a contraction in annual revenue and a widening of the annual net loss.

Business & Operations Update

JELD-WEN reported a non-cash goodwill impairment charge of 129.2 million valuation expense against U.S. tax attributes. Operational restructuring included a realignment of the workforce and targeted cost actions. The company operates facilities in 14 countries and employs approximately 13,900 associates.

M&A or Strategic Moves

The company completed the court-ordered divestiture of its Towanda facility in the first quarter of 2025, receiving 37.6 million.

ADVERTISEMENT

Guidance & Outlook

For 2026, the company issued revenue guidance between $2.95 billion and $3.1 billion. This range reflects an expected core revenue decline of 5% to 10% and a foreign exchange benefit of approximately 100 million to $150 million and operating cash flow of approximately $40 million.

Performance Summary

  • Fourth-quarter revenue was $802.0 million.
  • Net loss narrowed to $40.1 million.
  • North America revenue decreased 18.4% while Europe revenue increased 9.4%.
  • Full-year 2025 revenue contracted 14.9%.
  • 2026 revenue guidance is set between $2.95 billion and $3.1 billion.

 

ADVERTISEMENT